Home New England Sudbury, MA Gentuity, LLC COMPANY
FDA-cleared device company
Also known as Gentuity · 16 open jobs · last seen Oct 23, 2026 · 5 sources
Profile checked Oct 10, 2026
Keywords: Coronary Artery Disease Anatomy Coronary Stenosis
Hiring Title Location (from posting) Employer posted First seen Senior/Staff Software Engineer Sudbury MA Oct 21, 2026 Oct 22, 2026 FP&A Manager Sudbury MA Oct 9, 2026 Oct 11, 2026 Corporate Controller Sudbury MA Oct 9, 2026 Oct 11, 2026 Quality Engineer Co-Op Sudbury MA Oct 8, 2026 Oct 11, 2026 Process Development Engineering Co-Op Sudbury MA Oct 8, 2026 Oct 11, 2026
See all 16 jobs
At a glance HQ Sudbury, MA source Region New England Stage FDA-cleared device company Latest trial —: Vis-Rx Prime Micro-Imaging Catheter Study (Dec 11, 2024) source Timeline Jan 31, 2025 FDA FDA 510(k) clearance: Gentuity® HF-OCT Imaging System with Vis-Rx Prime® Micro-Imaging Catheter — K242966, Jan 31, 2025. Applicant at approval: Gentuity, LLC. source ↗ Dec 11, 2024 Trial start —: Vis-Rx Prime Micro-Imaging Catheter Study source ↗ Feb 13, 2023 Trial start Not phased (device or behavioral study): Clinical Feasibility Evaluation of the Gentuity HF-OCT Imaging System With Vis-M Micro-Imaging Catheter source ↗ Mar 14, 2022 Trial start —: Physio-Anatomy Clinical Data Collection Study source ↗ Feb 22, 2021 Trial start —: Vis-Rx Post-Market Evaluation source ↗ Clinical trials (lead sponsor) 4 Record Title Phase Status Start Primary completion NCT06685783 Vis-Rx Prime Micro-Imaging Catheter Study Not listed Completed Dec 11, 2024 Apr 30, 2025 (actual) NCT06078878 Clinical Feasibility Evaluation of the Gentuity HF-OCT Imaging System With Vis-M Micro-Imaging Catheter Not phased (device or behavioral study) Recruiting Feb 13, 2023 2026-09 (estimated) NCT04533503 Vis-Rx Post-Market Evaluation Not listed Completed Feb 22, 2021 Jan 25, 2023 (actual) NCT05312164 Physio-Anatomy Clinical Data Collection Study Not listed Recruiting Mar 14, 2022 Dec 31, 2025 (estimated)
FDA records (last 2 years) Jan 31, 2025 FDA 510(k) clearance: Gentuity® HF-OCT Imaging System with Vis-Rx Prime® Micro-Imaging Catheter — K242966, Jan 31, 2025. Applicant at approval: Gentuity, LLC. source ↗ Open jobs 16 Title Location (from posting, not HQ) Employer posted First seen Level Senior/Staff Software Engineer Sudbury MA Oct 21, 2026 Oct 22, 2026 Not stated FP&A Manager Sudbury MA Oct 9, 2026 Oct 11, 2026 Mid Description Corporate Controller Sudbury MA Oct 9, 2026 Oct 11, 2026 Senior Description Quality Engineer Co-Op Sudbury MA Oct 8, 2026 Oct 11, 2026 Entry Description Process Development Engineering Co-Op Sudbury MA Oct 8, 2026 Oct 11, 2026 Entry Description Test Engineer - Software & Systems Co-Op Sudbury MA Oct 8, 2026 Oct 11, 2026 Entry Description Systems Engineer Co-Op Sudbury MA Oct 8, 2026 Oct 11, 2026 Entry Description R&D Engineering - Disposables Co-Op Sudbury MA Oct 8, 2026 Oct 11, 2026 Entry Description Sales Rep - Detroit Remote Worker - N/A Oct 2, 2026 Oct 11, 2026 Not stated Sales Rep - Chicago Remote Worker - N/A Oct 2, 2026 Oct 11, 2026 Not stated Sales Rep - Salt Lake City Remote Worker - N/A Oct 2, 2026 Oct 11, 2026 Not stated Sales Rep - Denver Remote Worker - N/A Oct 2, 2026 Oct 11, 2026 Not stated Sr. R&D Engineer Sudbury MA Sep 29, 2026 Oct 11, 2026 Senior Description Facilities Technician Sudbury MA Sep 24, 2026 Oct 11, 2026 Mid Description Electro Mechanical Assembler Bedford/Sudbury MA Sep 14, 2026 Oct 11, 2026 Entry Description Senior System Engineer Sudbury MA Jul 23, 2026 Oct 11, 2026 Senior Description
Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.
Connect See your connections at Gentuity on LinkedIn (search by name, results not checked) LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.
LinkedIn page linked from the company's own site: source · seen 2026-10-12